Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children

Sulaiman M. Al-Mayouf, Nora AlMutiari, Mohammed Muzaffer, Rawiah shehata, Adel Al-Wahadneh, Reem Abdwani, Safia Al-Abrawi, Mohammed Abu-shukair, Zeyad El-Habahbeh, Abdullah Alsonbul

Research output: Contribution to journalArticle

Abstract

This study describes the disease characteristics and outcome of Arab children with juvenile dermatomyositis (JDM) and compares the findings with other ethnicities. We retrospectively reviewed the hospital registries of the participating hospitals for children with JDM seen between 1990 and 2016 in three Arab countries. All patients fulfilled Bohan and Peter criteria for JDM, diagnosed before 14 years of age and were of Arab ethnicity. Clinical and laboratory features as well as the long-term outcomes including accrual disease damage were collected at the last follow-up visit. A total of 92 JDM patients (58 girls) were included. Mean age at the onset was 6 ± 3 years, with a mean follow-up duration of 5 ± 4.4 years. Forty-three patients (46.7%) had polycyclic disease course, 34 (36.9%) had a monocyclic course, while 15 (16.3%) had a continuous progressive course. Forty-five patients (48.9%) had arthritis, 14 (15.2%) patients had an upper airway and dysphagia, and 10 patients (10.9%) had lung involvement. Eight patients (8.7%) were admitted to the intensive care unit (ICU), 4 of them required mechanical ventilation. Methotrexate had been the most frequently used immunosuppressive drug (86%) and rituximab was used in eight patients. Additionally, 31 patients received IVIG. Most of the patients achieved a complete clinical response, but 16 ended up with permanent skin changes and 12 had a residual muscle weakness. Twenty-seven patients developed calcinosis. There were two deaths due to infection during the follow-up period. We report the largest phenotypic data on Arab children with JDM. Our patients have similar characteristics to previously described cohorts. Majority of the patients remained with inactive disease.

Original languageEnglish
Pages (from-to)1513-1517
Number of pages5
JournalRheumatology International
Volume37
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Juvenile dermatomyositis
Calcinosis
Middle East
Intravenous Immunoglobulins
Muscle Weakness
Immunosuppressive Agents
Deglutition Disorders
Age of Onset
Artificial Respiration
Methotrexate
Arthritis
Intensive Care Units
Registries
Lung
Skin
Infection
Pharmaceutical Preparations
Rituximab

Keywords

  • Arab
  • Calcinosis
  • Disease damage
  • Juvenile dermatomyositis
  • Outcome

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Al-Mayouf, S. M., AlMutiari, N., Muzaffer, M., shehata, R., Al-Wahadneh, A., Abdwani, R., ... Alsonbul, A. (2017). Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children. Rheumatology International, 37(9), 1513-1517. https://doi.org/10.1007/s00296-017-3770-x

Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children. / Al-Mayouf, Sulaiman M.; AlMutiari, Nora; Muzaffer, Mohammed; shehata, Rawiah; Al-Wahadneh, Adel; Abdwani, Reem; Al-Abrawi, Safia; Abu-shukair, Mohammed; El-Habahbeh, Zeyad; Alsonbul, Abdullah.

In: Rheumatology International, Vol. 37, No. 9, 01.09.2017, p. 1513-1517.

Research output: Contribution to journalArticle

Al-Mayouf, SM, AlMutiari, N, Muzaffer, M, shehata, R, Al-Wahadneh, A, Abdwani, R, Al-Abrawi, S, Abu-shukair, M, El-Habahbeh, Z & Alsonbul, A 2017, 'Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children', Rheumatology International, vol. 37, no. 9, pp. 1513-1517. https://doi.org/10.1007/s00296-017-3770-x
Al-Mayouf, Sulaiman M. ; AlMutiari, Nora ; Muzaffer, Mohammed ; shehata, Rawiah ; Al-Wahadneh, Adel ; Abdwani, Reem ; Al-Abrawi, Safia ; Abu-shukair, Mohammed ; El-Habahbeh, Zeyad ; Alsonbul, Abdullah. / Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children. In: Rheumatology International. 2017 ; Vol. 37, No. 9. pp. 1513-1517.
@article{78e4076b8a584623820e37a06f9fb7c7,
title = "Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children",
abstract = "This study describes the disease characteristics and outcome of Arab children with juvenile dermatomyositis (JDM) and compares the findings with other ethnicities. We retrospectively reviewed the hospital registries of the participating hospitals for children with JDM seen between 1990 and 2016 in three Arab countries. All patients fulfilled Bohan and Peter criteria for JDM, diagnosed before 14 years of age and were of Arab ethnicity. Clinical and laboratory features as well as the long-term outcomes including accrual disease damage were collected at the last follow-up visit. A total of 92 JDM patients (58 girls) were included. Mean age at the onset was 6 ± 3 years, with a mean follow-up duration of 5 ± 4.4 years. Forty-three patients (46.7{\%}) had polycyclic disease course, 34 (36.9{\%}) had a monocyclic course, while 15 (16.3{\%}) had a continuous progressive course. Forty-five patients (48.9{\%}) had arthritis, 14 (15.2{\%}) patients had an upper airway and dysphagia, and 10 patients (10.9{\%}) had lung involvement. Eight patients (8.7{\%}) were admitted to the intensive care unit (ICU), 4 of them required mechanical ventilation. Methotrexate had been the most frequently used immunosuppressive drug (86{\%}) and rituximab was used in eight patients. Additionally, 31 patients received IVIG. Most of the patients achieved a complete clinical response, but 16 ended up with permanent skin changes and 12 had a residual muscle weakness. Twenty-seven patients developed calcinosis. There were two deaths due to infection during the follow-up period. We report the largest phenotypic data on Arab children with JDM. Our patients have similar characteristics to previously described cohorts. Majority of the patients remained with inactive disease.",
keywords = "Arab, Calcinosis, Disease damage, Juvenile dermatomyositis, Outcome",
author = "Al-Mayouf, {Sulaiman M.} and Nora AlMutiari and Mohammed Muzaffer and Rawiah shehata and Adel Al-Wahadneh and Reem Abdwani and Safia Al-Abrawi and Mohammed Abu-shukair and Zeyad El-Habahbeh and Abdullah Alsonbul",
year = "2017",
month = "9",
day = "1",
doi = "10.1007/s00296-017-3770-x",
language = "English",
volume = "37",
pages = "1513--1517",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children

AU - Al-Mayouf, Sulaiman M.

AU - AlMutiari, Nora

AU - Muzaffer, Mohammed

AU - shehata, Rawiah

AU - Al-Wahadneh, Adel

AU - Abdwani, Reem

AU - Al-Abrawi, Safia

AU - Abu-shukair, Mohammed

AU - El-Habahbeh, Zeyad

AU - Alsonbul, Abdullah

PY - 2017/9/1

Y1 - 2017/9/1

N2 - This study describes the disease characteristics and outcome of Arab children with juvenile dermatomyositis (JDM) and compares the findings with other ethnicities. We retrospectively reviewed the hospital registries of the participating hospitals for children with JDM seen between 1990 and 2016 in three Arab countries. All patients fulfilled Bohan and Peter criteria for JDM, diagnosed before 14 years of age and were of Arab ethnicity. Clinical and laboratory features as well as the long-term outcomes including accrual disease damage were collected at the last follow-up visit. A total of 92 JDM patients (58 girls) were included. Mean age at the onset was 6 ± 3 years, with a mean follow-up duration of 5 ± 4.4 years. Forty-three patients (46.7%) had polycyclic disease course, 34 (36.9%) had a monocyclic course, while 15 (16.3%) had a continuous progressive course. Forty-five patients (48.9%) had arthritis, 14 (15.2%) patients had an upper airway and dysphagia, and 10 patients (10.9%) had lung involvement. Eight patients (8.7%) were admitted to the intensive care unit (ICU), 4 of them required mechanical ventilation. Methotrexate had been the most frequently used immunosuppressive drug (86%) and rituximab was used in eight patients. Additionally, 31 patients received IVIG. Most of the patients achieved a complete clinical response, but 16 ended up with permanent skin changes and 12 had a residual muscle weakness. Twenty-seven patients developed calcinosis. There were two deaths due to infection during the follow-up period. We report the largest phenotypic data on Arab children with JDM. Our patients have similar characteristics to previously described cohorts. Majority of the patients remained with inactive disease.

AB - This study describes the disease characteristics and outcome of Arab children with juvenile dermatomyositis (JDM) and compares the findings with other ethnicities. We retrospectively reviewed the hospital registries of the participating hospitals for children with JDM seen between 1990 and 2016 in three Arab countries. All patients fulfilled Bohan and Peter criteria for JDM, diagnosed before 14 years of age and were of Arab ethnicity. Clinical and laboratory features as well as the long-term outcomes including accrual disease damage were collected at the last follow-up visit. A total of 92 JDM patients (58 girls) were included. Mean age at the onset was 6 ± 3 years, with a mean follow-up duration of 5 ± 4.4 years. Forty-three patients (46.7%) had polycyclic disease course, 34 (36.9%) had a monocyclic course, while 15 (16.3%) had a continuous progressive course. Forty-five patients (48.9%) had arthritis, 14 (15.2%) patients had an upper airway and dysphagia, and 10 patients (10.9%) had lung involvement. Eight patients (8.7%) were admitted to the intensive care unit (ICU), 4 of them required mechanical ventilation. Methotrexate had been the most frequently used immunosuppressive drug (86%) and rituximab was used in eight patients. Additionally, 31 patients received IVIG. Most of the patients achieved a complete clinical response, but 16 ended up with permanent skin changes and 12 had a residual muscle weakness. Twenty-seven patients developed calcinosis. There were two deaths due to infection during the follow-up period. We report the largest phenotypic data on Arab children with JDM. Our patients have similar characteristics to previously described cohorts. Majority of the patients remained with inactive disease.

KW - Arab

KW - Calcinosis

KW - Disease damage

KW - Juvenile dermatomyositis

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=85022061217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022061217&partnerID=8YFLogxK

U2 - 10.1007/s00296-017-3770-x

DO - 10.1007/s00296-017-3770-x

M3 - Article

AN - SCOPUS:85022061217

VL - 37

SP - 1513

EP - 1517

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 9

ER -